Related Experiment Video
Updated: Jul 7, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Current concepts in malignant pleural mesothelioma
Andrew J Kaufman1, Harvey I Pass
1New York University Medical Center, Department of Surgery, 550 First Avenue, NBV-15N1, New York, NY 10016, USA. kaufma01@med.nyu.edu
Abstract:
Malignant pleural mesothelioma (MPM) is a rare but lethal cancer associated with asbestos exposure. Worldwide, the incidence of MPM is expected to increase over the next 20 years. The molecular and genetic profiling of MPM tumors and patients, and improved understanding of the pathogenesis of MPM may lead to novel diagnostic, preventative and therapeutic strategies. Treatment options for MPM remain limited and no consensus exists at this time. Multimodality therapy that combines surgery, chemotherapy and radiation offers the best chance for long-term survival in select patients.
Insights
Malignant pleural mesothelioma (MPM) is a deadly cancer linked to asbestos. Research into MPM
Area of Science:
- Oncology
- Pathology
Background:
- Malignant pleural mesothelioma (MPM) is a rare, lethal cancer.
- Asbestos exposure is the primary cause of MPM.
- MPM incidence is projected to rise globally over the next two decades.
Purpose of the Study:
- To explore novel diagnostic, preventative, and therapeutic strategies for MPM.
- To advance understanding of MPM pathogenesis through molecular and genetic profiling.
Main Methods:
- Molecular and genetic profiling of MPM tumors and patients.
- Review of current and potential treatment strategies.
Main Results:
- Limited treatment options currently exist for MPM with no established consensus.
- Multimodality therapy (surgery, chemotherapy, radiation) offers the best survival chance for select patients.
Conclusions:
- Further research into MPM pathogenesis is crucial for developing new treatments.
- Multimodality therapy is the current best approach for eligible MPM patients.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Pleura of the Lungs
The Tumor Microenvironment

